Emerging Technology Platforms for Drug Discovery and Development

USD 950

* Required Fields

USD 950

PAY BY INVOICE

Be the first to review this product

The latest edition of the Drug Discovery TechVision Opportunity Engine (TOE) profiles emerging technology platforms for drug discovery and development. These platforms are diverse and span the spectrum of the life sciences industry, from tissue engineering to companion diagnostics, biomarkers, and cell therapy. This TOE issue strikes a balance between innovations at the academia research setting and technologies that have received regulatory approval and have been commercialized.

The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Companion diagnostics, tissue engineering, biomarkers, artificial intelligence, cell therapy

Table of Contents

Emerging Technology Platforms for Drug Discovery and DevelopmentInnovations in Drug DiscoveryEngineered Tissue-based High Content Analysis to Optimize Preclinical ValidationAccelerating Precision Medicine through Companion DiagnosticsCombining Advanced Genomics and Artificial Intelligence for Cancer TherapeuticsGenetically Targeted Drugs Addressing Cancer Therapeutics Discovery ChallengesFDA Approved Therapy for NSCLC with BRAF V600E mutationFull FDA Approval for Blinatumomab for Treatment of Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia in Adults and ChildrenAnti-Malarial Drug Re-positioned to Target Genetic Mutations in Amyotrophic Lateral Sclerosis Precision MedicineTechnology Focus and TrendsTechnology Focus and Trends in Precision MedicineThree Start Ups to NoteBiomarker-based Drug Discovery – Industry InteractionsIndustry InteractionsIndustry Interactions (continued)




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 10-Nov-17

Region : Global

Release Date : 10-Nov-17

Region : Global

Release Date : 09-Nov-17

Region : Global

Release Date : 03-Nov-17

Region : Global

Release Date : 31-Oct-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.